In conclusion, our findings demonstrated that genetical or pharmacological PLK1 inhibition selectively induced TERT downregulation, cell cycle arrest and apoptosis in HCC cells harbouring TERT promoter mutations through Smad3. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.